share_log

4: Statement of changes in beneficial ownership of securities-Officer Glover Stephen C.

4: Statement of changes in beneficial ownership of securities-Officer Glover Stephen C.

4:持股變動聲明-高管 Glover Stephen C.
美股SEC公告 ·  2024/07/19 09:36

Moomoo AI 已提取核心訊息

Stephen C. Glover, the Chief Executive Officer of ZyVersa Therapeutics, Inc. (ZVSA), was involved in a transaction with the company's stock on May 24, 2023. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, were not disclosed in the announcement. Consequently, the number of shares held by Glover after the transaction remains unknown.
Stephen C. Glover, the Chief Executive Officer of ZyVersa Therapeutics, Inc. (ZVSA), was involved in a transaction with the company's stock on May 24, 2023. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, were not disclosed in the announcement. Consequently, the number of shares held by Glover after the transaction remains unknown.
2023年5月24日,ZyVersa Therapeutics, Inc. (ZVSA) 的首席執行官Stephen C. Glover參與了一項交易。公告中未公開交易的具體細節,包括交易的股份數量、股份性質、交易價格以及交易總價值。因此,交易後Glover持有的股份數量仍未知。
2023年5月24日,ZyVersa Therapeutics, Inc. (ZVSA) 的首席執行官Stephen C. Glover參與了一項交易。公告中未公開交易的具體細節,包括交易的股份數量、股份性質、交易價格以及交易總價值。因此,交易後Glover持有的股份數量仍未知。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息